Events2Join

GE Healthcare Acquires Asymptote


GE Healthcare acquires Asymptote for complete, digitally-enabled ...

GE Healthcare has acquired Asymptote Limited, specialists in cryochain technology for sensitive cellular therapies.

GE Healthcare Purchases Asymptote

GE Healthcare has recently purchased Asymptote. Founder and CEO of Asymptote, John Morris, is a long time member of the Society for Cryobiology.

GE Healthcare Adds to Its Cell Therapy Portfolio by Acquiring ...

GE Healthcare said today it has acquired Asymptote for an undisclosed price in a deal that the buyer said would strengthen its cell therapy portfolio.

GE acquires British cold chain specialist, deepening cell therapy push

GE Healthcare has acquired the British cold-chain technology specialist Asymptote, Ltd, aiming to boost its capabilities in the growing ...

GE Healthcare gains digitally-enabled cryogenic cold chain ...

GE Healthcare acquires Asymptote, gaining a suite of technologies for the cryopreservation of cellular materials.

GE Healthcare Adds to Its Cell Therapy Portfolio with Acquisition of ...

GE Healthcare recently announced the acquisition of British cryogenic processing company Asymptote for an undisclosed price, strengthening its cell therapy ...

GE Healthcare announces takeover of Asymptote - Zenopa

GE Healthcare has announced the acquisition of Asymptote, a purchase that will strengthen its capabilities in the field of cell therapy.

GE Healthcare acquires Asymptote Ltd. - 2017-04-11 - Crunchbase

Asymptote specialists in cryochain technology for sensitive cellular therapies. Acquiring Organization: GE Healthcare Logo. GE Healthcare GE Healthcare provides ...

GE Healthcare Acquires Asymptote | Mergr M&A Deal Summary

On April 10, 2017, GE Healthcare acquired medical products company Asymptote. Acquisition Highlights. This is GE Healthcare's 10th transaction in the ...

GE Invests in Cold-Chain and Mfg Software

GE Healthcare has invested in cold-chain technology and automated manufacturing software through its acquisition of Asymptote, a Cambridge, ...

GE Healthcare: The Next Cell and Gene Therapy Manufacturing ...

GE Healthcare continues to ramp up its offerings in the bioprocessing space with the purchase of Asymptote and a continued partnership with ...

GE aiming to be cell therapy production services one-stop-shop

GE Healthcare has acquired cryopreservation technology firm Asymptote and says more investments are likely as it builds an “end-to-end ...

Asymptote Ltd. - Crunchbase Company Profile & Funding

was acquired by GE Healthcare on Apr 11, 2017 . Transaction Name.

Enabling the development of potentially life-saving therapies

Growth of SME: Asymptote was acquired by GE Healthcare in 2017. Development ... The subsequent acquisition of Asymptote by GE Healthcare in 2017 enabled ...

Asymptote Archives - Evolution Search Partners

[vc_row][vc_column][vc_column_text]GE Healthcare recently announced the acquisition of British cryogenic processing company Asymptote for an undisclosed price, ...

Asymptote Company Profile 2024: Valuation, Investors, Acquisition

Asymptote. Asymptote Overview. Update this profile. Year ... Asymptote was acquired by GE HealthCare Technologies. Data Transparency. Meet ...

List of 33 Acquisitions by GE Healthcare (Oct 2024) - Tracxn

Recent acquisitions by GE Healthcare ; Acquired on. Apr 11, 2017 ; Acquired Company. Asymptote ; Acquisition Price. Undisclosed ; Stake Acquired.

Newly renamed Cytiva retains heart of GE Healthcare's biopharma ...

... Asymptote Ltd., of Cambridge, U.K., a company GE Healthcare acquired in 2017. Asymptote had received several grants from the U.K. innovation ...

GE HealthCare announces agreement to acquire clinical artificial ...

GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC's (Intelligent Ultrasound) clinical ...

Investing in Cures for Cancer: GE Poised to Lead Industrialization of ...

Chalfont St Giles, UK - 13 July 2016 - GE Healthcare has acquired Biosafe Group SA, a supplier of integrated cell bioprocessing systems for ...